Skip to main content
Slovak Republic
Global Fin Swe Nor Den Ger Cze Svk Pol Hun Nld Bel (nl) Bel (fr) USA
  • Aidian – Your aid in diagnostics
  • Produkty
  • O nás
  • Novinky
  • Udržateľnosť
  • Antimikrobiálna rezistencia
  • Aidian Academy
  • Skúsenosti zákazníkov
Kontaktujte nás Vyhľadávanie
Logo
Kontaktujte nás
  • POCT
  • Monitorovanie hygieny
  • Mikrobiológia
  • Molekulárna mikrobiológia
  • Infekcie dýchacích ciest
  • Iný
POCT
  • Systém QuikRead go
  • QuikRead 101
  • ACRO™ Biotech
  • LabPad®
Čítaj viac
QuikRead go
  • QuikRead go Plus Instrument
  • QuikRead go Instrument
  • QuikRead go easy CRP
  • QuikRead go CRP
  • QuikRead go CRP+Hb
  • QuikRead go wrCRP
  • QuikRead go wrCRP+Hb
  • QuikRead go HbA1c
  • QuikRead go Strep A
  • QuikRead go iFOBT
  • QuikRead go príslušenstvo
QuikRead go
Monitorovanie hygieny
  • Easicult
  • Hygicult
  • Clean Card PRO
Čítaj viac
Mikrobiológia
  • Uricult
  • Cultura M
  • Meridian Immunoassays
  • Meridian Curian®
Čítaj viac
Molekulárna mikrobiológia
  • Meridian Revogene®
  • Meridian Alethia®
Čítaj viac
Iný
  • Grifols Promonitor®
Čítaj viac
  • Aidian na Slovensku
  • Predstavenstvo a manažment
  • Udržateľnosť
  • Firemná kultúra
  • Kariéra
  • Novinky
  • Novinky o produktoch
  • AMR
  • Udalosti
  • Stories from customers
  • COVID-19
  • Aidian na Slovensku
  • Firemná kultúra
  • Udržateľnosť
Udržateľnosť
  • Životné prostredie
  • Zdravie
  • Sociálna oblasť
Čítaj viac
  • Informácia o C-reaktívnom proteíne (CRP)
  • CRP a infekcie dolných dýchacích ciest
  • Vzdelávacie materiály
  • Produkty QuikRead go CRP
  • Šírenie baktérií rezistentných na antibiotiká
  • Useful links
  • Všeobecne
  • Informácie o produktoch
  • Kurzy
  • Dokumenty a materiály
  • Často kladené otázky
  • POCT testovanie
  • Hygiena spánku: kontrola čistoty vankúšov a posteľnej bielizne
Logo
Kontaktujte nás Zavrieť
  • Produkty
    • POCT
      • Systém QuikRead go
      • QuikRead 101
      • ACRO™ Biotech
      • LabPad®
    • Monitorovanie hygieny
      • Easicult
      • Hygicult
      • Clean Card PRO
    • Mikrobiológia
      • Uricult
      • Cultura M
      • Meridian Immunoassays
      • Meridian Curian®
    • Molekulárna mikrobiológia
      • Meridian Revogene®
      • Meridian Alethia®
    • Infekcie dýchacích ciest
    • Iný
      • Grifols Promonitor®
  • O nás
    • Aidian na Slovensku
    • Predstavenstvo a manažment
    • Udržateľnosť
    • Firemná kultúra
    • Kariéra
  • Novinky
    • Novinky
    • Novinky o produktoch
    • AMR
    • Udalosti
    • Stories from customers
    • COVID-19
  • Udržateľnosť
    • Aidian na Slovensku
    • Firemná kultúra
    • Udržateľnosť
      • Životné prostredie
      • Zdravie
      • Sociálna oblasť
  • Antimikrobiálna rezistencia
    • Informácia o C-reaktívnom proteíne (CRP)
    • CRP a infekcie dolných dýchacích ciest
    • Vzdelávacie materiály
    • Produkty QuikRead go CRP
    • Šírenie baktérií rezistentných na antibiotiká
    • Useful links
  • Aidian Academy
    • Všeobecne
    • Informácie o produktoch
    • Kurzy
    • Dokumenty a materiály
    • Často kladené otázky
  • Skúsenosti zákazníkov
    • POCT testovanie
    • Hygiena spánku: kontrola čistoty vankúšov a posteľnej bielizne
Obľúbené produkty
Cultura M

Cultura M

QuikRead go Plus Instrument

QuikRead go Plus Instrument

Test Clean Card PRO

Test Clean Card PRO

Najnovšie správy
Zobraziť všetko

Predstavujeme vám prístroj QuikRead go Plus!

12. novembra 2024 | Novinky, Novinky o produktoch

Včasná diagnostika streptokoka A zabezpečuje rýchlu liečbu a minimálne šírenie infekcie

28. februára 2024 | Novinky, Novinky o produktoch

Aidian – Váš pomocník v diagnostike od roku 1974

18. februára 2024 | Novinky

  • Zobraziť všetko
  • Neboli nájdené žiadne výsledky
  • Loading...
Správy

Predstavujeme vám prístroj QuikRead go Plus!

12. novembra 2024 | Novinky, Novinky o produktoch

Včasná diagnostika streptokoka A zabezpečuje rýchlu liečbu a minimálne šírenie infekcie

28. februára 2024 | Novinky, Novinky o produktoch

Späť na všetky novinky
23. augusta 2022
Novinky,
AMR,
COVID-19

COVID-19 pandemic has contributed to the aggravation of Antimicrobial Resistance

Antimicrobial resistance (AMR) is an emerging health threat, but the COVID-19 pandemic set back many actions already combating AMR. Before COVID-19, Antimicrobial stewardship programs and National Actions Plans significantly progressed to slow down Antimicrobial Resistance in many countries. Due to the emergency in the healthcare systems caused by COVID-19, many planned activities were deprioritized and already integrated preventive actions were reversed1,2. For example, antibiotics were prescribed more often without diagnostic confirmation about bacterial infection than before the pandemic1,3.

Recently, the US Centers for Disease Control and Prevention reported that after several years of decrease, antimicrobial resistant hospital-onset infections and deaths increased by at least 15% during the first year of the pandemic. The change in trend indicates that AMR preventive actions must be readdressed and integrated back into the healthcare systems.

Antibiotics were commonly prescribed for hospitalized COVID-19 patients

Antibiotics do not cure viral infections, such as COVID-19, but bacterial co-infections may sometimes accompany viral infections. Treating COVID-19 patients with antibiotics, especially in the early pandemic, seemed to be rather a rule than an exception in many countries. There were concerns about bacterial co-infections, and difficulties in differentiating COVID-19 from community-acquired pneumonia that led excessive antibiotic use. In the USA and China, 80-100% of hospitalized COVID-19 patients received antibiotics1,4. However, bacterial co-infections were reported only on 7-8% of hospitalized and 14% of intensive care patients4, which suggests that antibiotics were often inappropriately used in the treatment of COVID-19.

A person holding a medicine bottle and a pill

The use of broad-spectrum antibiotics increased during COVID-19

In primary care, overall antibiotic consumption decreased in many countries during COVID-19 due to fewer visits to primary care and less spread of respiratory infection. However, the consumption of broad-spectrum antibiotics increased in the EU/EEA countries in both primary care and hospitals.5 Also, in the USA, broad-spectrum antibiotics were commonly used in hospitalized COVID-19 patients1. Broad-spectrum antibiotics are effective against a wide range of bacteria. They are not a first option treatment: they should be used only to treat severe bacterial infections. Therefore, it is necessary to use them correctly to prevent the development of resistance to these drugs.

Immediate actions are needed to optimize antibiotic use and prevent AMR

Now it is more urgent than ever to focus on AMR and reinforce antimicrobial stewardship programs to ensure the appropriate use of antibiotics and other AMR preventive actions in healthcare. Performing fast and accurate point of care tests before antibiotic prescribing, such as QuikRead go CRP and Strep A tests, are an efficient way to optimize antibiotic prescribing and prevent the development of antibiotic resistant bacteria.

Find our portfolio for CRP and Strep A point of care tests from our website: Point of care / QuikRead go


References

  1. Centers of Disease Control and Prevention (CDC). COVID-19: U.S. Impact on Antimicrobial Resistance, Special report 2022. Atlanta, GA: U.S. Department of Health and Human Services. https://www.cdc.gov/drugresistance/pdf/covid19-impact-report-508.pdf
  2. Pan American Health Organization. Antimicrobial Resistance, Fueled by the COVID-19 Pandemic. Policy Brief November 2021. https://iris.paho.org/handle/10665.2/55864
  3. Mantzourani et al. To swab or not to swab? Using point-of-care tests to detect Group A Streptococcus infections as part of a Sore Throat Test and Treat service in community pharmacy. J Antimicrobial Chemoter 2021; 77:803–806.
  4. Lansbury et al. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect 2020;81(2):266–275.
  5. Organisation for Economic Co-operation and Development (OECD), European Centre for Disease Control and Prevention (ECDC), European Food Safety Authority (EFSA) and European Medicines Agency (EMA). Briefing note: Antimicrobial Resistance in the EU/EEA: A One Health Response. 2022.
Share
Facebook
Twitter
Email

Aidian Oy

Aidian Slovakia s.r.o.
Karadžičova 8/A
821 08 Bratislava - Ružinov



+421 944 541 700



info@aidian.sk

Spoločnosť
  • O nás
  • Udržateľnosť
  • Kariéra
  • Kontaktujte nás
Produkty
  • POCT
  • Monitorovanie hygieny
  • Mikrobiológia
  • Molekulárna mikrobiológia
  • Infekcie dýchacích ciest
  • Iný
Rýchle odkazy
  • Aidian Academy
  • Aidian Connect
Copyright © 2025 Aidian
  • Politika ochrany údajov
  • Vyhlásenie o ochrane súkromia
  • Zásady používania súborov cookie
  • Zásady pre používanie sociálnych sietí